Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.58%||177.12||0.7%||$1156.59m|
|LLY||Eli Lilly & Co.||0.96%||372.06||1.1%||$1068.92m|
|MRK||Merck & Co., Inc.||1.06%||110.08||0.7%||$1002.54m|
|BMY||Bristol-Myers Squibb Co.||0.01%||79.93||1.1%||$742.00m|
|HZNP||Horizon Therapeutics Plc||-0.57%||96.30||5.4%||$286.44m|
|IDXX||IDEXX Laboratories, Inc.||1.13%||420.10||3.9%||$191.38m|
|ALNY||Alnylam Pharmaceuticals, Inc.||5.32%||231.33||8.0%||$168.15m|
|NVO||Novo Nordisk A/S||-0.42%||125.26||0.1%||$152.07m|
United Therapeutics Corp. operates as a biotechnology company engaged in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It is involved in the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. The company was founded by Martine A. Rothblatt on June 26, 1996, and is headquartered in Silver Spring, MD.